Toyoki Moribe∥

925 total citations
22 papers, 750 citations indexed

About

Toyoki Moribe∥ is a scholar working on Molecular Biology, Immunology and Hepatology. According to data from OpenAlex, Toyoki Moribe∥ has authored 22 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Immunology and 6 papers in Hepatology. Recurrent topics in Toyoki Moribe∥'s work include Epigenetics and DNA Methylation (5 papers), Hepatitis C virus research (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Toyoki Moribe∥ is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Hepatitis C virus research (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Toyoki Moribe∥ collaborates with scholars based in Japan, United States and Germany. Toyoki Moribe∥'s co-authors include Norio Hayashi, Toshihiko Kaneshige, Norio Iizuka, Kazuhiko Sakamoto, Takao Tamesa, Hideo Ishitsuka, Hideyuki Fusamoto, Yoshiyuki Kanazawa, Akinori Kasahara and Shigeru Tamatsukuri and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Toyoki Moribe∥

20 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toyoki Moribe∥ Japan 12 383 325 208 181 105 22 750
Martin Krüger Germany 12 381 1.0× 240 0.7× 301 1.4× 63 0.3× 193 1.8× 13 890
Masatoshi Deguchi Japan 14 158 0.4× 157 0.5× 257 1.2× 73 0.4× 110 1.0× 42 643
Maarten Penning Netherlands 11 285 0.7× 246 0.8× 183 0.9× 93 0.5× 85 0.8× 19 565
Ming‐Yang Lai Taiwan 15 428 1.1× 428 1.3× 125 0.6× 100 0.6× 85 0.8× 18 667
W. Schraut Germany 6 212 0.6× 284 0.9× 102 0.5× 172 1.0× 168 1.6× 13 716
Hans‐Peter Dienes Germany 12 179 0.5× 181 0.6× 202 1.0× 76 0.4× 160 1.5× 18 696
Bettina Langhans Germany 17 562 1.5× 420 1.3× 117 0.6× 49 0.3× 149 1.4× 46 1.0k
Tomoyuki Kawakita Japan 12 104 0.3× 103 0.3× 284 1.4× 167 0.9× 112 1.1× 22 630
Julia Dietz Germany 17 460 1.2× 401 1.2× 171 0.8× 42 0.2× 60 0.6× 50 776
Sheng Zhong Hong Kong 9 897 2.3× 938 2.9× 384 1.8× 190 1.0× 279 2.7× 10 1.5k

Countries citing papers authored by Toyoki Moribe∥

Since Specialization
Citations

This map shows the geographic impact of Toyoki Moribe∥'s research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toyoki Moribe∥ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toyoki Moribe∥ more than expected).

Fields of papers citing papers by Toyoki Moribe∥

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toyoki Moribe∥. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toyoki Moribe∥. The network helps show where Toyoki Moribe∥ may publish in the future.

Co-authorship network of co-authors of Toyoki Moribe∥

This figure shows the co-authorship network connecting the top 25 collaborators of Toyoki Moribe∥. A scholar is included among the top collaborators of Toyoki Moribe∥ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toyoki Moribe∥. Toyoki Moribe∥ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Iizuka, Norio, Toyoki Moribe∥, Toshiaki Miura, et al.. (2010). Methylated cyclin D2 gene circulating in the blood as a prognosis predictor of hepatocellular carcinoma. Clinica Chimica Acta. 411(7-8). 516–520. 23 indexed citations
4.
Tsunedomi, Ryouichi, Yasushi Ogawa, Norio Iizuka, et al.. (2010). The assessment of methylated BASP1 and SRD5A2 levels in the detection of early hepatocellular carcinoma.. PubMed. 36(1). 205–12. 19 indexed citations
5.
Kimura, Naoki, Toyoki Moribe∥, Norio Iizuka, et al.. (2009). Rapid and quantitative detection of CpG-methylation status using TaqMan PCR combined with methyl-binding-domain polypeptide. Clinical Biochemistry. 42(10-11). 1113–1122. 5 indexed citations
6.
Moribe∥, Toyoki, Norio Iizuka, Toshiaki Miura, et al.. (2009). Methylation of multiple genes as molecular markers for diagnosis of a small, well‐differentiated hepatocellular carcinoma. International Journal of Cancer. 125(2). 388–397. 96 indexed citations
7.
Tokuhisa, Yoshihiro, Norio Iizuka, Isao Sakaida, et al.. (2007). Circulating cell-free DNA as a predictive marker for distant metastasis of hepatitis C virus-related hepatocellular carcinoma. British Journal of Cancer. 97(10). 1399–1403. 84 indexed citations
8.
Iizuka, Norio, Isao Sakaida, Toyoki Moribe∥, et al.. (2007). Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma.. PubMed. 26(6C). 4713–9. 77 indexed citations
9.
Moribe∥, Toyoki, et al.. (2002). Rapid and simultaneous HLA class I (‐A, ‐B and ‐C loci) DNA typing using the microtitre plate–reverse hybridization assay (MRHA). European Journal of Immunogenetics. 29(3). 191–204. 1 indexed citations
10.
Kuzushita, Noriyoshi, Norio Hayashi, Tatsuya Kanto, et al.. (1999). Involvement of transporter associated with antigen processing 2 (TAP2) gene polymorphisms in hepatitis C virus infection. Gastroenterology. 116(5). 1149–1154. 31 indexed citations
12.
Kuzushita, Noriyoshi, Norio Hayashi, Toyoki Moribe∥, et al.. (1998). Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology. 27(1). 240–244. 118 indexed citations
13.
Nakamura, Ken, Hiroshi Shijo, Nobuhiro Kimura, et al.. (1998). Analysis of Human T-Cell Antigen Receptor Variable β Gene Usage Following Vaccination with Recombinant HBsAg. Digestive Diseases and Sciences. 43(4). 880–886. 5 indexed citations
14.
Kaneshige, Toshihiko, Mitsuo Hashimoto, Tomoko Kinoshita, et al.. (1997). Haplotypic diversity of DQA1*03 and *05 subtypes differing at amino acid residue 160 encoded in the third exon in 2215 Japanese individuals. Tissue Antigens. 49(1). 46–52. 4 indexed citations
15.
Moribe∥, Toyoki, Toshihiko Kaneshige, & Hidetoshi Inoko. (1997). Complete HLA‐A DNA typing using the PCR‐RFLP method combined with allele group‐ and sequence‐specific amplification. Tissue Antigens. 50(5). 535–545. 17 indexed citations
16.
Yuki, Nobukazu, Norio Hayashi, Toyoki Moribe∥, et al.. (1997). Relation of Disease Activity During Chronic Hepatitis C Infection to Complexity of Hypervariable Region 1 Quasispecies. Hepatology. 25(2). 439–444. 39 indexed citations
17.
Moribe∥, Toyoki, et al.. (1996). Identification of a DRB1*0405 variant (DRB1*04052) using the PCR-RFLP method.. PubMed. 47(5). 450–3. 11 indexed citations
18.
Moribe∥, Toyoki, Norio Hayashi, Yoshiyuki Kanazawa, et al.. (1995). Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy. Gastroenterology. 108(3). 789–795. 94 indexed citations
19.
Kaneshige, Toshihiko, et al.. (1994). Direct sequencing of a novel DPB1 allele (DPB1*5101) of the heterozygote from the membrane of reverse dot blot analysis. Tissue Antigens. 44(3). 204–207. 8 indexed citations
20.
Moribe∥, Toyoki. (1992). Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search. International Journal of Oncology. 33(5). 949–58. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026